Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2001
10/18/2001CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001CA2405004A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them
10/18/2001CA2404994A1 Pyrazolo-triazine derivatives as ligands for gaba receptors
10/18/2001CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001CA2404971A1 Human protein kinases and protein kinase-like enzymes
10/18/2001CA2404273A1 Substituted lactams as inhibitors of a.beta. protein production
10/18/2001CA2404229A1 Human transporters and ion channels
10/18/2001CA2403012A1 Chemical compounds
10/18/2001CA2402410A1 The high bone mass gene of 11q13.3
10/18/2001CA2401290A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001CA2306170A1 Novel amino, carboxy derivatives of barbituric acid
10/17/2001EP1146044A1 CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
10/17/2001EP1146041A1 Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline
10/17/2001EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/17/2001EP1144671A2 Enriched central nervous system cell populations
10/17/2001EP1144651A1 Polypeptides derived from jnk3
10/17/2001EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001EP1144634A2 Novel complex-forming proteins
10/17/2001EP1144630A2 Human cell signaling proteins (csig)
10/17/2001EP1144628A2 Human vanilloid receptor gene
10/17/2001EP1144625A2 Nucleic-acid binding proteins
10/17/2001EP1144623A1 Method and medicament for inhibiting the expression of a defined gene
10/17/2001EP1144614A2 33 human secreted proteins
10/17/2001EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001EP1144592A2 Substrate for cell growth
10/17/2001EP1144591A2 Low oxygen culturing of cells
10/17/2001EP1144453A1 Anti-ccr4 antibodies and methods of use therefor
10/17/2001EP1144443A2 Human membrane transport proteins
10/17/2001EP1144441A2 Disintegrin homologs
10/17/2001EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144431A2 16-hydroxyestratrienes as selective estrogens
10/17/2001EP1144425A1 Derivatives of monosaccharides as cell adhesion inhibitors
10/17/2001EP1144413A1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses
10/17/2001EP1144409A2 Phenyl urea and phenyl thiourea derivatives
10/17/2001EP1144408A1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
10/17/2001EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144386A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144372A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
10/17/2001EP1144371A1 Benzenesulphonamide derivatives and their use as mek inhibitors
10/17/2001EP1144370A2 Thyroid receptor ligands
10/17/2001EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001EP1144050A2 Binding partners for 5-ht5-receptors for the treatment of migraine
10/17/2001EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001EP1143977A1 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1143975A1 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
10/17/2001EP1143974A1 Pharmaceutical compositions for alleviating discomfort
10/17/2001EP1143971A1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use
10/17/2001EP1143967A2 Use of anticonvulsant derivatives for treating cluster headaches
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
10/17/2001EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001EP1143947A2 Use of estrogen compounds for prevention and treatment of ischemic damage
10/17/2001EP1143943A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
10/17/2001EP1143942A2 Use of gaba-b receptor ligands for the treatment of neurodegenerative diseases
10/17/2001EP1143938A2 Phinan
10/17/2001EP1143936A2 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN $g(a)-ANTAGONIST
10/17/2001EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001EP0999841B1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
10/17/2001EP0983265A4 Endothelin receptor antagonists
10/17/2001EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/17/2001EP0796251B1 Uracil derivatives
10/17/2001EP0776201B1 Treating anxiety
10/17/2001EP0769965B1 Aqueous risperidone formulations
10/17/2001EP0759744B1 Narcotic containing aerosol formulation
10/17/2001EP0751766B1 Nasal and ocular administration of ketamine to manage pain and for detoxification
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/17/2001EP0641330B1 Gaba and l-glutamic acid analogs for antiseizure treatment
10/17/2001CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation
10/17/2001CN1318054A Novel compounds
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317969A Treatment of depression
10/17/2001CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P
10/17/2001CN1317964A Composition
10/17/2001CN1317963A Composition
10/17/2001CN1317493A Preparing process and application of undecapeptide
10/17/2001CN1317490A Novel-6-sulfamine-3-quinolyl phosphonate compounds, its prepn. process and medical compsn. contg. them
10/17/2001CN1317489A Novel aryl radical or heteroaryl radical quinolyl phosphonate compounds, its preparing method and medical compsn. contg. them
10/17/2001CN1317480A One-step process for synthetizing 2-oxazolidone derivative
10/17/2001CN1317341A Medical application of heptadecapeptide
10/17/2001CN1317333A Chinese patent medicine for dropping off drug
10/17/2001CN1317321A Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process
10/17/2001CN1317315A Tendon-comfortable analgesic
10/17/2001CN1317313A Application of tea polyphenol in preparing medicine to suppress beta-amyloid aggregation and fibroplasia
1 ... 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 ... 1833